Differences in Acinetobacter baumannii strains and host innate immune response determine morbidity and mortality in experimental pneumonia

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  de Breij, Anna ^a   Eveillard, Matthieu ^b   Dijkshoorn, Lenie ^a   van den Broek, Peterhans J ^a   Nibbering, Peter H ^a   Joly Guillou, Marie Laure ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 23;

ACINETOBACTER BAUMANNII; ACINETOBACTER JUNII; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BACTERIAL STRAIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; EUROPEAN UNION; EXPERIMENTAL PNEUMONIA; FEMALE; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; MORBIDITY; MORTALITY; MOUSE; NONHUMAN; PNEUMONIA; STRAIN DIFFERENCE; ACINETOBACTER INFECTION; ANIMAL; BLOOD; IMMUNOLOGY; LUNG; MICROBIOLOGY; PATHOGENICITY;

ACINETOBACTER BAUMANNII; BACTERIA (MICROORGANISMS); MUS;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANIMALS; CYTOKINES; IMMUNITY, INNATE; INFLAMMATION; LUNG; MICE; MORBIDITY; MORTALITY; PNEUMONIA;

EID: 84856700592     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030673     Document Type: Article

References (34)

1. Dijkshoorn L, Aucken H, Gerner-Smidt P, Janssen P, Kaufmann ME, et al. (1996) Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. J Clin Microbiol 34: 1519-1525.
2. Van Dessel H, Dijkshoorn L, van der Reijden T, Bakker N, Paauw A, et al. (2004) Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals. Res Microbiol 155: 105-112.
3. Seifert H, Dijkshoorn L, Gerner-Smidt P, Pelzer N, Tjernberg I, et al. (1997) Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods. J Clin Microbiol 35: 2819-2825.
4. Dijkshoorn L, Nemec A, Seifert H, (2007) An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 5: 939-951.
5. De Breij A, Dijkshoorn L, Lagendijk E, van der Meer J, Koster A, et al. (2010) Do biofilm formation and interactions with human cells explain the clinical success of Acinetobacter baumannii? PLoS One 5: e10732.
6. King LB, Swiatlo E, Swiatlo A, McDaniel LS, (2009) Serum resistance and biofilm formation in clinical isolates of Acinetobacter baumannii. FEMS Immunol Med Microbiol 55: 414-421.
7. Lee HW, Koh YM, Kim J, Lee JC, Lee YC, et al. (2008) Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. Clin Microbiol Infect 14: 49-54.
8. Lee JC, Koerten H, van den Broek P, Beekhuizen H, Wolterbeek R, et al. (2006) Adherence of Acinetobacter baumannii strains to human bronchial epithelial cells. Res Microbiol 157: 360-366.
9. Tomaras AP, Dorsey CW, Edelmann RE, Actis LA, (2003) Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. Microbiology 149: 3473-3484.
10. Van Looveren M, Goossens H, (2004) Antimicrobial resistance of Acinetobacter spp. in Europe. Clin Microbiol Infect 10: 684-704.
11. Webster C, Towner KJ, Humphreys H, (2000) Survival of Acinetobacter on three clinically related inanimate surfaces. Infect Control Hosp Epidemiol 21: 246.
12. Knapp S, Wieland CW, Florquin S, Pantophlet R, Dijkshoorn L, et al. (2006) Differential roles of CD14 and toll-like receptors 4 and 2 in murine Acinetobacter pneumonia. Am J Respir Crit Care Med 173: 122-129.
13. Qiu H, KuoLee R, Harris G, Chen W, (2009) High susceptibility to respiratory Acinetobacter baumannii infection in A/J mice is associated with a delay in early pulmonary recruitment of neutrophils. Microbes Infect 11: 946-955.
14. Van Faassen H, KuoLee R, Harris G, Zhao X, Conlan JW, et al. (2007) Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice. Infect Immun 75: 5597-5608.
15. Eveillard M, Soltner C, Kempf M, Saint-Andre JP, Lemarie C, et al. (2010) The virulence variability of different Acinetobacter baumannii strains in experimental pneumonia. J Infect 60: 154-161.
16. Kapetanovic R, Cavaillon JM, (2007) Early events in innate immunity in the recognition of microbial pathogens. Expert Opin Biol Ther 7: 907-918.
17. De Breij A, Gaddy J, van der Meer J, Koning R, Koster A, et al. (2009) CsuA/BABCDE-dependent pili are not involved in the adherence of Acinetobacter baumannii ATCC19606(T) to human airway epithelial cells and their inflammatory response. Res Microbiol 160: 213-218.
18. Gaddy JA, Tomaras AP, Actis LA, (2009) The Acinetobacter baumannii 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells. Infect Immun 77: 3150-3160.
19. Lee JS, Choi CH, Kim JW, Lee JC, (2010) Acinetobacter baumannii outer membrane protein A induces dendritic cell death through mitochondrial targeting. J Microbiol 48: 387-392.
20. Nwugo CC, Gaddy JA, Zimbler DL, Actis LA, (2011) Deciphering the iron response in Acinetobacter baumannii: A proteomics approach. J Proteomics 74: 44-58.
21. Tomaras AP, Flagler MJ, Dorsey CW, Gaddy JA, Actis LA, (2008) Characterization of a two-component regulatory system from Acinetobacter baumannii that controls biofilm formation and cellular morphology. Microbiology 154: 3398-3409.
22. Dijkshoorn L, Brouwer CP, Bogaards SJ, Nemec A, van den Broek PJ, et al. (2004) The synthetic N-terminal peptide of human lactoferrin, hLF(1-11), is highly effective against experimental infection caused by multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 48: 4919-4921.
23. Breslow JM, Meissler JJ Jr, Hartzell RR, Spence PB, Truant A, et al. (2011) Innate immune responses to systemic Acinetobacter baumannii infection in mice: neutrophils, but not interleukin-17, mediate host resistance. Infect Immun 79: 3317-3327.
24. Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S, (2010) The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One 5: e10034.
25. Turton JF, Gabriel SN, Valderrey C, Kaufmann ME, Pitt TL, (2007) Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. Clin Microbiol Infect 13: 807-815.
26. Jeong ES, Won YS, Kim HC, Cho MH, Choi YK, (2009) Role of IL-10 deficiency in pneumonia induced by Corynebacterium kutscheri in mice. J Microbiol Biotechnol 19: 424-430.
27. Mittal R, Gonzalez-Gomez I, Panigrahy A, Goth K, Bonnet R, et al. (2010) IL-10 administration reduces PGE-2 levels and promotes CR3-mediated clearance of Escherichia coli K1 by phagocytes in meningitis. J Exp Med 207: 1307-1319.
28. Greenberger MJ, Strieter RM, Kunkel SL, Danforth JM, Goodman RE, et al. (1995) Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J Immunol 155: 722-729.
29. Van der Poll T, Marchant A, Keogh CV, Goldman M, Lowry SF, (1996) Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis 174: 994-1000.
30. Happel KI, Dubin PJ, Zheng M, Ghilardi N, Lockhart C, et al. (2005) Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J Exp Med 202: 761-769.
31. Mednick AJ, Feldmesser M, Rivera J, Casadevall A, (2003) Neutropenia alters lung cytokine production in mice and reduces their susceptibility to pulmonary cryptococcosis. Eur J Immunol 33: 1744-1753.
32. McKenzie BS, Kastelein RA, Cua DJ, (2006) Understanding the IL-23-IL-17 immune pathway. Trends Immunol 27: 17-23.
33. Dijkshoorn L, van Harsselaar B, Tjernberg I, Bouvet PJ, Vaneechoutte M, (1998) Evaluation of amplified ribosomal DNA restriction analysis for identification of Acinetobacter genomic species. Syst Appl Microbiol 21: 33-39.
34. Nemec A, de Baere T, Tjernberg I, Vaneechoutte M, van der Reijden TJ, et al. (2001) Acinetobacter ursingii sp. nov. and Acinetobacter schindleri sp. nov., isolated from human clinical specimens. Int J Syst Evol Microbiol 51: 1891-1899.